Category: Include on Menu

  • CoStar Shares Slide After Revenue Guidance Overshadows Strong Profit Growth

    CoStar Shares Slide After Revenue Guidance Overshadows Strong Profit Growth

    CoStar Group (NASDAQ:CSGP) shares dropped 14.3% in pre-market trading after the real estate data and marketplace company released second-quarter 2026 results that exceeded earnings expectations but disappointed investors with weaker-than-expected revenue guidance and a reduced full-year outlook. Although profitability improved significantly during the quarter, the market focused on slowing revenue growth and softer booking trends,…

  • KLA Shares Drop Despite Q4 Earnings Beat as Guidance Fails to Impress Investors

    KLA Shares Drop Despite Q4 Earnings Beat as Guidance Fails to Impress Investors

    KLA Corporation (NASDAQ:KLAC) reported stronger-than-expected fiscal fourth-quarter results, but its shares fell more than 10% in pre-market trading on Wednesday after investors focused on a cautious near-term outlook and guidance that offered only limited upside. The semiconductor equipment manufacturer posted earnings per share of $1.05 for the quarter, exceeding analysts’ expectations of $1.00. Revenue came…

  • Teradyne Shares Rise After Record Quarterly Results and Strong Q3 Outlook

    Teradyne Shares Rise After Record Quarterly Results and Strong Q3 Outlook

    Teradyne (NASDAQ:TER) shares climbed 4.4% in pre-market trading after the semiconductor testing equipment manufacturer reported a second consecutive quarter of record revenue and issued third-quarter guidance that significantly exceeded Wall Street expectations, extending gains that began in after-hours trading following the earnings release. The company reported its second-quarter 2026 results after the market closed on…

  • AbbVie Secures EU Approval for Rinvoq to Treat Severe Alopecia Areata

    AbbVie Secures EU Approval for Rinvoq to Treat Severe Alopecia Areata

    AbbVie (NYSE:ABBV) has received European Commission approval for Rinvoq (upadacitinib) as a treatment for severe alopecia areata (AA) in adults and adolescents aged 12 years and older, expanding the medicine’s approved uses across the European Union. The therapy will be available in 15 mg and 30 mg once-daily doses for eligible patients. Phase 3 Studies…

  • Gold Edges Higher as Weaker Dollar Supports Prices Ahead of Fed Decision

    Gold Edges Higher as Weaker Dollar Supports Prices Ahead of Fed Decision

    Gold prices moved modestly higher on Wednesday as a softer U.S. dollar provided support for bullion ahead of the Federal Reserve’s latest interest rate announcement, while renewed geopolitical tensions in the Middle East and stronger oil prices kept inflation concerns firmly on investors’ radar. Spot gold (XAU/USD) rose 0.3% to $4,038.71 an ounce by 04:52…

  • Oil Prices Climb as Middle East Tensions Intensify Following Iraq Strikes and Missile Interception

    Oil Prices Climb as Middle East Tensions Intensify Following Iraq Strikes and Missile Interception

    Oil prices surged by more than 3% on Wednesday after military tensions in the Middle East intensified following joint U.S. and Saudi strikes against Iran-backed groups in Iraq, an intercepted Iranian missile attack targeting U.S. forces, and signs of tightening U.S. crude supplies. Brent crude futures climbed $3.04, or 3.6%, to $87.13 a barrel by…

  • Markets Hold Steady Ahead of Fed Decision as Investors Await Microsoft and Meta Results: Dow Jones, S&P, Nasdaq, Wall Street Futures

    Markets Hold Steady Ahead of Fed Decision as Investors Await Microsoft and Meta Results: Dow Jones, S&P, Nasdaq, Wall Street Futures

    U.S. stock futures traded close to unchanged on Wednesday as investors prepared for a pivotal session featuring the Federal Reserve’s latest interest rate decision and quarterly earnings from artificial intelligence leaders Meta Platforms (NASDAQ:META) and Microsoft (NASDAQ:MSFT). Meanwhile, renewed military tensions in the Middle East pushed oil prices sharply higher, adding another layer of uncertainty…

  • Dow Jumps More Than 500 Points as Rotation Out of Chips Lifts Wall Street

    Dow Jumps More Than 500 Points as Rotation Out of Chips Lifts Wall Street

    Stocks finished mixed on Tuesday as investors continued to rotate out of high-flying chipmakers and into more economically sensitive and defensive corners of the market. Strong corporate earnings and a sharp drop in oil prices helped power the Dow Jones Industrial Average to a gain of more than 500 points, even as weakness in semiconductor…

  • Virtuix Expands Defense Business with U.S. Marine Corps Counter-Drone Training Program

    Virtuix Expands Defense Business with U.S. Marine Corps Counter-Drone Training Program

    Virtuix Holdings (NASDAQ:VTIX) announced that its Omni One full-body movement platform has been integrated into a next-generation counter-drone training simulator that will be evaluated by the U.S. Marine Corps, further expanding the company’s presence in the defense training market. Key Investor Takeaways Why VTIX Stock Is in Focus Virtuix announced that its Omni One movement…

  • Travelzoo Reports Q2 2026 Loss as Membership Strategy Weighs on Near-Term Results

    Travelzoo Reports Q2 2026 Loss as Membership Strategy Weighs on Near-Term Results

    Travelzoo (NASDAQ:TZOO) reported a second-quarter 2026 loss as geopolitical uncertainty and continued investment in its paid membership strategy weighed on revenue and profitability, while management maintained expectations for revenue growth in the second half of the year. Key Investor Takeaways Why TZOO Stock Is in Focus Travelzoo reported second-quarter revenue of $23.2 million, down 3%…